Comment on Komé et al. One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.
Diabetes Care July 1, 2025 DOI: 10.2337/dc25-0566 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractA commentary on Komé et al. argues that microdosing semaglutide from multidose pens is not a one-size-fits-all approach and that individualization is necessary for diabetes management.
Study at a glance
| Characteristics | Commentary Peer reviewed |
|---|---|
| Key finding | Argues that microdosing semaglutide with multidose pens is unsafe and not recommended due to risk of dosing inaccuracies. |
Abstract
Comment on Komé et al. One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.